LISA BELETSIS: Open Payments
NPI 1962797787 · OROVILLE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,755 in 120 payments from 15 companies in 2025. Trend: 2023 $713 · 2024 $996 · 2025 $2,755
Food & beverage: $2,755
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $419 |
| Axsome Therapeutics, Inc. | 13 | $360 |
| Vanda Pharmaceuticals Inc. | 19 | $348 |
| Teva Pharmaceuticals USA, Inc. | 7 | $339 |
| Alkermes, Inc. | 14 | $322 |
| Neurocrine BioSciences, Inc. | 11 | $286 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $192 |
| Bausch Health US, LLC | 10 | $188 |
| Almatica Pharma LLC | 3 | $66 |
| IDORSIA PHARMACEUTICALS US INC | 2 | $53 |
Products named: VRAYLAR, Auvelity, FANAPT, ARISTADA, AUSTEDO XR, INGREZZA, CAPLYTA, APLENZIN.
Industry payments across CA — which companies pay providers there.
